Qu, C., Ping, N., Zou, R., He, J., Zhu, Q., Li, J., Zhang, X., Xia, F., Kong, D., He, S., Wu, D., Jin, Z. (2025). Dual epigenetic modulation with obinutuzumab/liposomal mitoxantrone in refractory or Relapsed Diffuse large B-cell lymphoma patients post-salvage therapy: A phase II study. Blood. https://doi.org/10.1182/blood-2025-5468